Assert-IQ vs Affiniti Series Diagnostic Ultrasound Systems

Assert-IQ offers a patient-centric mobile app (myMerlin) for symptom logging and data transmission via Bluetooth, simplifying patient interaction. Its remote programmability for clinicians reduces the need for in-clinic follow-ups, streamlining workflow for both patients and healthcare providers. While Affiniti focuses on operator efficiency with intuitive interfaces, Assert-IQ's extended usability to the patient and remote clinical management provides a broader advantage.

Assert-IQ provides long-term, continuous cardiac monitoring for up to 6 years with advanced AI algorithms that significantly reduce false positives for AF and pause episodes while maintaining high sensitivity. This leads to higher rates of AF diagnosis and oral anticoagulation implementation, offering sustained and proactive clinical impact. Affiniti offers advanced imaging for diverse needs, but Assert-IQ's continuous, AI-driven data for a critical, often intermittent condition provides a distinct advantage in long-term patient management.

Philips Affiniti Series offers transparent pricing with ranges for new and refurbished models, explicitly positioning itself as a 'mid tier' or 'budget' option with rich image quality. It also emphasizes low operating costs and a low total cost of ownership. Assert-IQ's pricing is enterprise-based and requires direct contact, lacking the transparency needed for a direct value comparison.

Both tools are FDA cleared and HIPAA compliant. Assert-IQ features a hybrid deployment with a secure cloud-based data platform and data export capabilities, explicitly targeting large health systems, hospitals, and cardiology clinics. Its remote programming and monitoring through Merlin.net Patient Care Network enhance workflow efficiency and scalability for large organizations. Affiniti's on-premise console system, while robust, offers less deployment flexibility compared to Assert-IQ's hybrid cloud approach.

Assert-IQ stands out with its combination of ultra-long-term continuous cardiac monitoring (up to 6 years), advanced AI algorithms for reducing false positives in arrhythmia detection, and remote programmability for an implantable device. It is highlighted as the 'only ICM system to combine AI, the longest-lasting Bluetoothu00ae ICM, and IQ Insights'. While Affiniti offers innovative imaging technologies like Anatomical Intelligence, Assert-IQ's comprehensive AI integration for continuous, long-term, and remote implantable monitoring represents a more unique and impactful innovation in its specific field.

Philips offers a comprehensive support ecosystem for its Affiniti series, including a Customer Services Portal for managing service tickets, dedicated technical support lines, an online community for imaging users, and extensive educational services with over 1,000 courses. While Abbott provides manuals and contact information for Assert-IQ, Philips' documented offerings appear more extensive and proactive in supporting its professional users.